Company Plans To Bring Chinese Medicines to U.S.

Selling health foods & medicines in China fuels rapid growth for American Oriental Bioengineering.

Ours is a very quick-developing company, even in China,” said Lily Li, chief operations officer of American Oriental Bioengineering Inc. (AOBO). Headquartered in Harbin, China, the maker of Chinese medicine and health food products has grown from $60,000 to over $50 million in the past four years, becoming one of China’s 10 most recognized brands.

All access premium subscription

This content requires a subscription to Nutrition Business Journal.

As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on newhope.com (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.

Email [email protected] for more information about subscribing.